Cabozantinib Promising for Advanced Adrenocortical Carcinoma

FRIDAY, April 26, 2024 -- For patients with advanced adrenocortical carcinoma, cabozantinib shows promising efficacy, according to a study published online April 9 in The Lancet Oncology. Matthew T. Campbell, M.D., from The University of Texas MD...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news